Topic: Oncology

Kite CAR-T manufacturing

CMS: Medicare will cover CAR T

Medicare will begin covering the growing collection of immunotherapy drugs referred to as CAR T-cell therapy for cancer patients being treated in some healthcare facilities, the Centers for Medicare & Medicaid Services announced Wednesday.